(Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus

Overview of attention for article published in Cochrane database of systematic reviews, November 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source
twitter: 9 tweeters

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 36 Dimensions

Readers on

mendeley: 223 Mendeley

Summary Policy documents Twitter Wikipedia Dimensions citations

So far, Dimensions has found 36 publications that cite this research output.

36

The most recent citing publications are shown below. View all 36 publications that cite this research output on Dimensions.

Issues of insulin therapy for type 2 diabetes and ways to solve them

Article in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (June 2023)

Long‐acting insulin analogues and the risk of diabetic retinopathy among patients with type 2 diabetes: A population‐based cohort study

Article in Diabetes Obesity and Metabolism (May 2023)

Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta‐analysis

Article in Journal of Diabetes (April 2023)